BioCheck, Inc. recalls T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use is For the qua…
- Recall date
- October 14, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0214-2022
- FDA classification
- Class II
- Brand / firm
- BioCheck, Inc.
- Sold / distributed
- US Distribution to states of: MI, FL, NJ, OH, CA; and OUS (foreign) distribution to countries of: Spain, Taiwan and Nigeria
Why it was recalled
Immunoassay TEST Kit do not meet product shelf-life standards resulting in failed controls.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
T4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use is For the quantitative determination of total thyroxine (T4) concentration in human serum. The test is useful in the diagnosis and treatment of thyroid disorders.
Get recall alerts
Free email alert whenever BioCheck, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: BioCheck, Inc.